Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acasti Pharma (NQ: ACST ) 3.090 +0.020 (+0.65%) Streaming Delayed Price Updated: 2:36 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Acasti Pharma < Previous 1 2 3 Next > Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing September 20, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Life Sciences Virtual Investor Forum Agenda Announced for September 19th September 16, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Recap: Acasti Pharma Q4 Earnings June 23, 2023 Via Benzinga Acasti Pharma's Earnings Outlook February 13, 2023 Via Benzinga ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025 August 09, 2024 ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the first quarter of 2025. Via InvestorPlace ACST Stock Earnings: Acasti Pharma Beats EPS for Q4 2024 June 21, 2024 ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the fourth quarter of 2024. Via InvestorPlace Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 June 18, 2024 Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities. Via InvestorPlace The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom May 23, 2024 These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress. Via InvestorPlace Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 26, 2023 Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... Via Benzinga Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 18, 2024 Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the... Via Benzinga Why Acasti Pharma (ACST) Stock Is Exploding Higher September 26, 2023 Acasti Pharma Inc (NASDAQ: ACST) shares are trading higher by 34.3% to $2.35 Tuesday morning after the company announced $7.5 million in private placement equity financing. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 09, 2023 We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! Via InvestorPlace Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 05, 2023 Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 22, 2023 The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning! Via InvestorPlace Acasti Pharma Reports Third Quarter 2023 Operational Results February 14, 2023 From Acasti Pharma, Inc. Via GlobeNewswire Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule January 25, 2023 From Acasti Pharma, Inc. Via GlobeNewswire Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31 January 24, 2023 From Acasti Pharma, Inc. Via GlobeNewswire Earnings Scheduled For February 14, 2023 February 14, 2023 Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. Via Benzinga Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day Podcast January 17, 2023 Phoenix, Arizona--(Newsfile Corp. - January 17, 2023) - The Stock Day Podcast welcomed Acasti Pharma, Inc. (NASDAQ: ACST), a late-stage... Via Newsfile Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18 January 13, 2023 From Acasti Pharma, Inc. Via GlobeNewswire Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket January 06, 2023 Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 06, 2023 The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! Via InvestorPlace Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures January 05, 2023 From Acasti Pharma, Inc. Via GlobeNewswire Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia December 28, 2022 From Acasti Pharma, Inc. Via GlobeNewswire Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session December 23, 2022 Gainers Via Benzinga Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket December 23, 2022 Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer... Via Benzinga Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN) December 22, 2022 From Acasti Pharma, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 December 19, 2022 Via Benzinga Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session December 20, 2022 Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 December 15, 2022 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.